Opinion: Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access
The Biden administration’s announcement that it would support waiving patent protections for Covid-19 vaccines to help spur production and access, especially among low-income countries, was a welcome step for increasing global access for these drugs at a time when they are desperately needed.
In justifying the move, Katherine Tai, the U.S. trade representative, said in a statement, “This is a global health crisis, and the extraordinary circumstances of the Covid-19 pandemic call for extraordinary measures.”
